Each vial contains antibody formulated with stabilizing components, 0.9 mg NaCl, 0.2 mg Na2HPO4, and 0.05 mg NaN3. *This antibody is supplied in a stabilized formulation. Compatibility with conjugation reactions depends on the chemistry of the conjugation
Formulierung:
Lyophilized
Target-Kategorie:
Tumor protein p73
Application Verdünnung:
Immunohistochemistry (Paraffin-embedded Section), 0.5-1µg/ml, Human, Mouse, Rat Western blot, 0.1-0.5µg/ml, Human
IHC(P) analysis of Human Intestinal Cancer Tissue using Anti-p73 antibody.
Anti-p73 antibody, IHC(P): Human Intestinal Cancer Tissue.
IHC(P) analysis of Rat Brain Tissue using Anti-p73 antibody.
Anti-p73 antibody, Western blotting. All lanes: Anti p73 at 0.5 ug/ml. Lane 1: HELA Whole Cell Lysate at 40 ug. Lane 2: MCF-7 Whole Cell Lysate at 40 ug. Lane 3: COLO320 Whole Cell Lysate at 40 ug. Predicted bind size: 73 KD. Observed bind size: 73 KD.
Anti-p73 antibody, Western blotting. All lanes: Anti p73 at 0.5 ug/ml. WB: Recombinant Human p73 Protein 0.5 ng. Predicted bind size: 45 KD. Observed bind size: 45 KD.
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten